Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 1

Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.

881 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 1 trial results

Completed

Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes

NCT01831765

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Mobile, Alabama, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Anaheim, California, United States
View all 191 locations
View Trial Details
Completed

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes

NCT02500706

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Encino, California, United States
  • Novo Nordisk Investigational Site Escondido, California, United States
View all 152 locations
View Trial Details
Completed

A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

NCT01835431

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Sacramento, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
View all 73 locations
View Trial Details
Completed

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

NCT02670915

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Long Beach, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
View all 155 locations
View Trial Details
Completed

Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus

NCT02662114

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Gentofte Municipality, Denmark
  • Novo Nordisk Investigational Site München, Germany
View Trial Details

Related conditions